company background image
FPH logo

Fisher & Paykel Healthcare CHIA:FPH Stock Report

Last Price

AU$34.20

Market Cap

AU$20.1b

7D

2.3%

1Y

57.3%

Updated

22 Dec, 2024

Data

Company Financials +

Fisher & Paykel Healthcare Corporation Limited

CHIA:FPH Stock Report

Market Cap: AU$20.1b

FPH Stock Overview

Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. More details

FPH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 24.05% per year

Risk Analysis

Significant insider selling over the past 3 months

Large one-off items impacting financial results

Profit margins (9.4%) are lower than last year (15.4%)


My Notes

Capture your thoughts, links and company narrative

Fisher & Paykel Healthcare Corporation Limited Competitors

Cochlear

ASX:COH

AU$18.9b

Sonic Healthcare

ASX:SHL

AU$13.0b

Ansell

ASX:ANN

AU$4.8b

Ramsay Health Care

ASX:RHC

AU$7.9b

Price History & Performance

Summary of share price highs, lows and changes for Fisher & Paykel Healthcare
Historical stock prices
Current Share PriceNZ$34.20
52 Week HighNZ$35.77
52 Week LowNZ$21.37
Beta0.38
1 Month Change-0.88%
3 Month Change2.60%
1 Year Change57.29%
3 Year Change10.63%
5 Year Change60.09%
Change since IPO765.70%

Recent News & Updates

Recent updates

Shareholder Returns

FPHAU Medical EquipmentAU Market
7D2.3%-1.1%-2.7%
1Y57.3%0.4%6.5%

Return vs Industry: FPH exceeded the Australian Medical Equipment industry which returned 0.4% over the past year.

Return vs Market: FPH exceeded the Australian Market which returned 6.5% over the past year.

Price Volatility

Is FPH's price volatile compared to industry and market?
FPH volatility
FPH Average Weekly Movement3.7%
Medical Equipment Industry Average Movement8.8%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.1%

Stable Share Price: FPH has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: FPH's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19347,005Lewis Gradonwww.fphcare.com

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.

Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary

How do Fisher & Paykel Healthcare's earnings and revenue compare to its market cap?
FPH fundamental statistics
Market capAU$20.13b
Earnings (TTM)AU$161.53m
Revenue (TTM)AU$1.71b

124.6x

P/E Ratio

11.8x

P/S Ratio

Is FPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FPH income statement (TTM)
RevenueNZ$1.89b
Cost of RevenueNZ$743.30m
Gross ProfitNZ$1.15b
Other ExpensesNZ$968.50m
EarningsNZ$178.50m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin60.68%
Net Profit Margin9.44%
Debt/Equity Ratio3.5%

How did FPH perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

137%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:24
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fisher & Paykel Healthcare Corporation Limited is covered by 26 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Saul HadassinBarrenjoey Markets Pty Limited
Lyanne HarrisonBofA Global Research